Literature DB >> 8620901

Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94.

M Guibourdenche1, E A Høiby, J Y Riou, F Varaine, C Joguet, D A Caugant.   

Abstract

A total of 125 strains of Neisseria meningitidis recovered in the course of outbreaks from patients with systemic disease in 11 African countries between 1989 and 1994 were analysed by serogrouping, serotyping and multilocus enzyme electrophoresis. Of the 125 patient strains 115 (92%) belonged to the clone-complex of serogroup A meningococci, designated subgroup III. Among the remaining strains, 4 were also serogroup A, but belonged to the clonal groups I and IV-1 (2 strains each), whilst 6 strains (4 serogroup C and 2 serogroup W135) represented clones of the ET-37 complex. Our results indicated that the second pandemic caused by clones of subgroup III is still spreading in Africa. Towards the West it has reached Niger, Mali, Guinea and The Gambia, and towards the South, the Central African Republic, Uganda, Rwanda, Burundi, Tanzania and Zambia.

Entities:  

Mesh:

Year:  1996        PMID: 8620901      PMCID: PMC2271617          DOI: 10.1017/s095026880005233x

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  21 in total

1.  Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA.

Authors:  E Wedege; E A Høiby; E Rosenqvist; L O Frøholm
Journal:  J Med Microbiol       Date:  1990-03       Impact factor: 2.472

Review 2.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

3.  Intercontinental spread of an epidemic group A Neisseria meningitidis strain.

Authors:  P S Moore; M W Reeves; B Schwartz; B G Gellin; C V Broome
Journal:  Lancet       Date:  1989-07-29       Impact factor: 79.321

4.  [Transport medium for meningococci].

Authors:  M Vandekerkove; P Bradstreet; R Faucon; S Benech
Journal:  Ann Inst Pasteur (Paris)       Date:  1967-08

Review 5.  Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983.

Authors:  T Olyhoek; B A Crowe; M Achtman
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug

6.  Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis.

Authors:  J F Wang; D A Caugant; G Morelli; B Koumaré; M Achtman
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

7.  Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae.

Authors:  G W Ajello; J C Feeley; P S Hayes; A L Reingold; G Bolan; C V Broome; C J Phillips
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

8.  Group A meningococcal carriage in travelers returning from Saudi Arabia.

Authors:  P S Moore; L H Harrison; E E Telzak; G W Ajello; C V Broome
Journal:  JAMA       Date:  1988-11-11       Impact factor: 56.272

9.  Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population.

Authors:  D A Caugant; E A Høiby; P Magnus; O Scheel; T Hoel; G Bjune; E Wedege; J Eng; L O Frøholm
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

Review 10.  Meningococcal disease: still with us.

Authors:  H Peltola
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb
View more
  8 in total

1.  Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger.

Authors:  Muhamed-Kheir Taha; Isabelle Parent Du Chatelet; Martin Schlumberger; Idrissa Sanou; Saacou Djibo; François de Chabalier; Jean-Michel Alonso
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.

Authors:  Christopher B Nelson; Maureen Birmingham; Alejandro Costa; Joelle Daviaud; William Perea; Marie-Paule Kieny; Daniel Tarantola
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

3.  Genetic analysis of a meningococcal population based on polymorphism of the pilA-pilB locus: a molecular approach for meningococcal epidemiology.

Authors:  M Guibourdenche; D Giorgini; A Guèye; M Larribe; J Y Riou; M K Taha
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 4.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 5.  Challenges and opportunities for meningococcal vaccination in the developing world.

Authors:  Rouba Shaker; Danielle Fayad; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

6.  Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.

Authors:  Zhigang Jin; Chiayung Chu; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaoundé, Cameroon.

Authors:  Marie-Christine Fonkoua; Muhamed-Kheir Taha; Pierre Nicolas; Patrick Cunin; Jean-Michel Alonso; Raymond Bercion; Jeanne Musi; Paul M V Martin
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

8.  Meningococcal disease and climate.

Authors:  Helena Palmgren
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.